Appendix 3Y Change of Director's Interest Notice
Appendix 3Y Change of Director's Interest NoticeRule 3.19A.2
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity: MEDIBANK PRIVATE LIMITED ABN: 47 080 890 259We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director | Linda Bardo Nicholls |
Date of last notice | 28 April 2016 |
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of ''notifiable interest of a director'' should be disclosed in this part.
Direct or indirect interest Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. | Indirect |
Interest in Medibank Private Limited Ordinary Shares ('Ordinary Shares') held by Pollard Strategy Associates Pty Ltd as the Trustee for PSA Superannuation Fund | |
Date of change | 1 September 2017 |
No. of securities held prior to change | 27,150 Ordinary Shares |
Class | Ordinary Shares |
Number acquired | 9,850 Ordinary Shares |
Number disposed | Nil |
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation | 9,850 Ordinary Shares at $3.04 per share |
No. of securities held after change | 37,000 Ordinary Shares |
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back | On-market purchase of Ordinary Shares |
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y
Change of Director's Interest Notice
Part 2 - Change of director's interests in contractsNote: In the case of a company, interests which come within paragraph (ii) of the definition of ''notifiable interest of a director'' should be disclosed in this part.
Detail of contract | N/A |
Nature of interest | N/A |
Name of registered holder (if issued securities) | N/A |
Date of change | N/A |
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed | N/A |
Interest acquired | N/A |
Interest disposed | N/A |
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation | N/A |
Interest after change | N/A |
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? | No |
If so, was prior written clearance provided to allow the trade to proceed during this period? | |
If prior written clearance was provided, on what date was this provided? |
+ See chapter 19 for defined terms.
Appendix 3Y Page 2 01/01/2011
Medibank Private Ltd. published this content on 07 September 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 07 September 2017 08:52:10 UTC.
Public permalinkhttp://www.publicnow.com/view/980E53A84A2FA5D955107AE80DD0A6A7B58A54E6